title: Anti-endothelial serum antibodies in a patient with Susac's syndrome.
abstract: BACKGROUND
  Susac's syndrome (SS) is a rare arteriopathy affecting the microvasculature of the brain, retina, and inner ear, resulting in encephalopathy, branch retinal artery occlusion and hearing loss. Anecdotal reports exist on SS being associated with a humoral immune response against endothelial cells. However, no original data has ever been published.
  
  
  OBJECTIVE
  To analyze serum and CSF from a patient with SS for the presence of CNS auto-antibodies and, if present, to further characterize such antibodies immunologically.
  
  
  METHODS
  Serum and CSF samples were examined by indirect immunofluorescence on adult mouse cerebrum, cerebellum, brain stem, and inner ear tissue sections, and IgG subclasses were determined.
  
  
  RESULTS
  Anti-endothelial antibodies were found at a titre of 1:960 in serum but not CSF. Antibodies belonged to the complement activating IgG1 subclass. Glucocorticoid treatment resulted in a decrease of titres (1:480), though the antibodies remained clearly detectable.
  
  
  CONCLUSIONS
  Our finding of anti-endothelial cell antibodies in a patient with SS is important in the light of previous pathological data suggesting that SS is associated with endothelial damage. Larger serological studies are now warranted to assess systematically the frequency and relevance of auto-antibodies in SS.
authors: Division of Molecular Neuroimmunology, Department of Neurology, University of Heidelberg, Im Neuenheimer Feld 400, D-69120 Heidelberg, Germany.
authors: S
authors: S
authors: Jarius
authors: B
authors: B
authors: Neumayer
authors: K P
authors: KP
authors: Wandinger
authors: M
authors: M
authors: Hartmann
authors: B
authors: B
authors: Wildemann
mesh_terms: D000818:Animals; D001323:Autoantibodies / Q000097:blood* / Q000134:cerebrospinal fluid / Q000378:metabolism; D001921:Brain / Q000378:metabolism / Q000473:pathology; D007758:Ear, Inner / Q000378:metabolism; D004727:Endothelium / Q000276:immunology* / Q000378:metabolism; D005260:Female; D005455:Fluorescent Antibody Technique; D005938:Glucocorticoids / Q000627:therapeutic use; D006801:Humans; D007074:Immunoglobulin G / Q000378:metabolism; D020765:Intracranial Arterial Diseases / Q000097:blood* / Q000134:cerebrospinal fluid / Q000188:drug therapy; D007759:Labyrinth Diseases / Q000097:blood* / Q000134:cerebrospinal fluid / Q000188:drug therapy; D008279:Magnetic Resonance Imaging; D051379:Mice; D008875:Middle Aged; D012164:Retinal Diseases / Q000097:blood* / Q000134:cerebrospinal fluid / Q000188:drug therapy; D013577:Syndrome; D016896:Treatment Outcome
chemical_list: D001323:Autoantibodies; D005938:Glucocorticoids; D007074:Immunoglobulin G